Medical Packaging Market: Rise in Demand for Counterfeit Prevention Mechanisms

According to our latest research study on “Medical Packaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Material, and Application,” the market is projected to reach US$ 169,183.91 million by 2028 from US$ 109,238.35 million in 2021; it is expected to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights trends prevailing in the market and the factors driving and restraining the market growth.

Medical packaging is essential in sustaining product quality and encouraging safe and effective use. Packaging is done for the safety of medical products for storage, distribution, sale, and use. The material used for packaging is a sterile barrier system that safeguards the drugs, equipment, and other medical products. Also, the medical packaging requires a high quality of sterility to ensure that the product is free from contamination. These medical packaging systems increase patient safety and enhance packaging performance. Factors such as increased emphasis on convenience and environmental issues and rise in demand for counterfeit prevention mechanisms are driving the medical packaging market. However, fluctuations in prices of raw materials are expected to restrict the market growth to a certain extent during the forecast period.

Download sample PDF Copy of Medical Packaging Market study at:  https://www.theinsightpartners.com/sample/TIPRE00005546/

The growth of the market is attributed to key driving factors such as increased emphasis on convenience and environmental issues and rise in demand for counterfeit prevention mechanisms. However, fluctuations in prices of raw materials are expected to restrict the market growth to a certain extent during the forecast period. Amcor plc; DuPont de Nemours, Inc.; Mitsubishi Chemical Corporation; SGD Pharma; 3M; West Pharmaceutical Services, Inc; Avery Dennison Corporation; Sonoco Products Company; CCL Industries Inc.; and WestRock Company are among the major companies operating in the market.

Rise in Demand for Counterfeit Prevention Mechanisms

Counterfeit medical products have been detected in most member states and all regions. Examples involved widely-used medicines such as atorvastatin or paracetamol; limited-use medicines such as growth hormone, paclitaxel, and filgastrim; and other kind of drugs such as sildenafil and tadalafil, as well as medical devices such as contact lenses, condoms, surgical mesh, and strips used by diabetic patients to monitor their blood glucose concentrations. Counterfeiting has affected both expensive and cheap products and generic and branded ones. Counterfeit products appear in community pharmacies, hospitals, and other less-regulated settings.

It is often assumed that high-income countries with solid regulatory systems can effectively exclude substandard and falsified medical products from their markets. However, the World Health Organization (WHO) analysis shows that this is not necessarily the case, as reports on these products have been submitted by countries in Western Europe and North America as well as other high-income settings. For example, a recent UK survey, carried out by Sapio Research and commissioned by a private company INCOPRO, concludes that almost one-third (32%) of those who have bought one or more counterfeit medicines have suffered a health issue as a result (INCOPRO, 2020). Numerous other documented cases in which patients have died or suffered harm due to an online purchase. As just one example, in 2013, people died after taking a counterfeit diet pill bought through an online drug seller. The pill, sold as a weight loss aid through many illicit online pharmacies, was actually a pesticide with lethal consequences for humans.

The threat that counterfeit medicines pose to the global pharmaceutical sector is immense. From fake formulations to issues in the manufacturing process, some industry figures believe we could be looking at revenue losses up to EUR 27 billion in Europe alone. The International Hologram Manufacturers Association (IHMA) is a good source of expertise in this field and highlights an industry report that indicates continued growth for anti-counterfeiting packaging technologies. According to the IHMA, the “Anti-counterfeiting, Authentication and Verification Technologies” report signals the added expertise holography brings to the authentication of packaging products. Technological innovation within the anti-counterfeiting, authentication, and verification technologies is a significant factor contributing to the market's growth.

Type-Based Insights

Based on type, the medical packaging market is categorized into containers, pouches, trays, blister packets, vials, and others. In 2021, the containers segment held the largest share of the market, by type. The blister packets segment is estimated to grow at significant CAGR during the forecast period due to increasing product developments and product launches.

Application-Based Insights

Based on application, the medical packaging market has been segmented into medical devices, pharmaceutical and biotechnology, medical equipment & tools, and others. In 2021, the pharmaceutical and biotechnology segment held the largest share of the market. The same segment is estimated to grow at a significant CAGR during the forecast period due to the growing production of pharmaceutical and biotechnology product in the global markets because of the increasing prevalence of chronic diseases.

Buy Complete Report of medical packaging Market Study at: https://www.theinsightpartners.com/buy/TIPRE00005546/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876